Home-based care model for patients with cirrhosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the Hospital at Home (H@H) model for patients with decompensated cirrhosis, aiming to understand their perspectives on home-based care. The study is divided into three phases: the first phase occurs while participants are hospitalized, the second phase involves the implementation of the H@H program, and the third phase focuses on rehabilitation and self-management. The program allows patients to receive acute medical care and ancillary services in their homes, potentially improving their quality of care and satisfaction. The study seeks to assess the effectiveness and feasibility of this model in managing liver disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Enrolled into IUH's H@H program
* At least 18 years of age
* Chronic liver disease/cirrhosis based on characteristic clinical, laboratory, and imaging findings
* English speaking
* Able to provide consent
* Caregiver able to be present during the acute phase of care (first 48 hours post-hospital discharge)
* Able to perform activities of daily living independently
* Lives within IU Health Home service area

Exclusion Criteria:

* Unable to complete study questionnaires due to neurocognitive disease, legal blindness or hearing loss
* Transplant of organ other than liver
* Pregnant
* Incarcerated
* New hemodialysis
* Blood pressure \< 90/60, Pulse \> 120, O2 \> 6L or \>2L above baseline
* HIV+/CD4 count \< 200
* Receiving hospice services
* Concurrent enrollment in a related research study

Where it's running

• IU School of Medicine
  Indianapolis, Indiana, United States Recruiting

Study contacts

• Study coordinator: Regia Weber
• Email: reginaw@iu.edu
• Phone: 317-278-3584

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Developing and validating a formula to detect major kidney events in people with decompensated cirrhosis and ascites

  This observational study aims to test a new equation that helps identify major adverse kidney events in adults with decompensated cirrhosis and ascites who have stable kidney function.

  Recruiting Institute of Liver and Biliary Sciences, India · New Delhi, National Capital Territory of Delhi · NCT07794787

• Comparing BCAA and Rifaximin for Preventing Hepatic Encephalopathy Recurrence

  This study is testing whether taking branched-chain amino acids or rifaximin can help people who have recently recovered from liver-related brain issues avoid having those problems come back.

  Recruiting Phase 4 Post Graduate Institute of Medical Education and Research, Chandigarh · Chandigarh · NCT06538077

• FMT for decompensated cirrhosis: a multicenter phase 3 test

  This phase 3 trial tests whether fecal microbiota transplantation from healthy donors can help people with decompensated cirrhosis.

  Recruiting at 8 sites Phase 3 Consorcio Centro de Investigación Biomédica en Red (CIBER) · Barcelona and 7 other locations · NCT06533852

• Carvedilol plus simvastatin versus carvedilol alone for cirrhosis-related heart dysfunction

  This trial will test whether adding simvastatin to carvedilol helps adults with cirrhosis and cirrhotic cardiomyopathy reduce liver decompensation and improve survival.

  Recruiting Post Graduate Institute of Medical Education and Research, Chandigarh · Chandigarh · NCT06431919

• Using smartphone technology to improve care for patients with cirrhosis

  This study is testing whether a new smartphone monitoring system can help people with advanced liver disease manage their condition better and avoid hospital visits compared to regular care.

  Recruiting at 14 sites University College, London · Birmingham and 14 other locations · NCT06223893

• Comparing antibiotic strategies for infected patients with cirrhosis

  This study tests whether using regular antibiotics or those chosen based on infection data works better for adults with cirrhosis and bacterial infections.

  Recruiting Phase 4 Institut d'Investigacions Biomèdiques August Pi i Sunyer · Barcelona · NCT05783661

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.